Assenagon Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,773
| Closed | -$21.6K | – | 1458 |
|
|
2024
Q2 | $21.6K | Hold |
19,773
| – | – | ﹤0.01% | 1361 |
|
|
2024
Q1 | $25.1K | Sell |
19,773
-52,643
| -73% | -$66.9K | ﹤0.01% | 1314 |
|
|
2023
Q4 | $101K | Sell |
72,416
-8,781
| -11% | -$12.2K | ﹤0.01% | 1337 |
|
|
2023
Q3 | $114K | Sell |
81,197
-100,665
| -55% | -$141K | ﹤0.01% | 1309 |
|
|
2023
Q2 | $335K | Buy |
181,862
+105,642
| +139% | +$194K | ﹤0.01% | 1171 |
|
|
2023
Q1 | $185K | Buy |
+76,220
| New | +$185K | ﹤0.01% | 1329 |
|
|
2022
Q3 | – | Sell |
-19,603
| Closed | -$41K | – | 1525 |
|
|
2022
Q2 | $41K | Buy |
+19,603
| New | +$41K | ﹤0.01% | 1380 |
|
|
2021
Q3 | – | Sell |
-11,793
| Closed | -$37K | – | 1415 |
|
|
2021
Q2 | $37K | Buy |
+11,793
| New | +$37K | ﹤0.01% | 1136 |
|
|
2019
Q2 | – | Sell |
-77,313
| Closed | -$211K | – | 1159 |
|
|
2019
Q1 | $211K | Buy |
77,313
+40,741
| +111% | +$111K | ﹤0.01% | 853 |
|
|
2018
Q4 | $102K | Sell |
36,572
-39,410
| -52% | -$110K | ﹤0.01% | 935 |
|
|
2018
Q3 | $313K | Buy |
+75,982
| New | +$313K | ﹤0.01% | 699 |
|